Inspire Medical Systems Price to Free Cash Flow Ratio 2017-2026 | INSP
Historical price to free cash flow ratio values for Inspire Medical Systems (INSP) since 2017.
| Inspire Medical Systems Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-16 | 72.75 | 18.38 | |
| 2026-06-30 | 44.61 | $3.96 | 11.27 |
| 2026-03-31 | 51.58 | $3.24 | 15.90 |
| 2025-12-31 | 92.23 | $2.64 | 34.97 |
| 2025-09-30 | 74.20 | $3.28 | 22.65 |
| 2025-06-30 | 129.77 | $2.76 | 47.00 |
| 2025-03-31 | 159.28 | $2.58 | 61.72 |
| 2024-12-31 | 185.38 | $2.98 | 62.14 |
| 2024-09-30 | 211.05 | $1.26 | 167.49 |
| 2024-06-30 | 133.83 | $-0.30 | 0.00 |
| 2024-03-31 | 214.79 | $0.11 | 1879.18 |
| 2023-12-31 | 203.43 | $0.03 | 5828.94 |
| 2023-09-30 | 198.44 | $0.30 | 663.68 |
| 2023-06-30 | 324.64 | $0.70 | 467.11 |
| 2023-03-31 | 234.07 | $0.42 | 556.91 |
| 2022-12-31 | 251.88 | $0.09 | 2859.02 |
| 2022-09-30 | 177.37 | $-0.48 | 0.00 |
| 2022-06-30 | 182.67 | $-0.82 | 0.00 |
| 2022-03-31 | 256.69 | $-0.98 | 0.00 |
| 2021-12-31 | 230.06 | $-0.91 | 0.00 |
| 2021-09-30 | 232.88 | $-1.15 | 0.00 |
| 2021-06-30 | 193.26 | $-1.44 | 0.00 |
| 2021-03-31 | 206.99 | $-1.94 | 0.00 |
| 2020-12-31 | 188.09 | $-2.13 | 0.00 |
| 2020-09-30 | 129.05 | $-2.17 | 0.00 |
| 2020-06-30 | 87.02 | $-1.99 | 0.00 |
| 2020-03-31 | 60.28 | $-1.64 | 0.00 |
| 2019-12-31 | 74.21 | $-1.49 | 0.00 |
| 2019-09-30 | 61.02 | $-1.76 | 0.00 |
| 2019-06-30 | 60.65 | $-1.42 | 0.00 |
| 2019-03-31 | 56.78 | $-1.78 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.157B | $0.912B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |